2012
1
Tanemura M., Ohmura Y., Deguchi T., Machida T., Tsukamoto R., Wada H., Kobayashi S., Marubashi S., Eguchi H., Ito T., Nagano H., Mori M., Doki Y. Rapamycin causes upregulation of autophagy and impairs islets function both in vitro and in vivo. Am J Transplant 12 102-114 2012
2
Takiguchi S., Adachi S., Yamamoto K., Morii E., Miyata H., Nakajima K., Yamasaki M., Kangawa K., Mori M., Doki Y. Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers. Dig Dis Sci 57 1238-1246 2012
3
Takiguchi S., Yamamoto K., Hirao M., Imamura H., Fujita J., Yano M., Kobayashi K., Kimura Y., Kurokawa Y., Mori M., Doki Y. A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer 15 198-205 2012
4
Takiguchi S., Hiura Y., Miyazaki Y., Takata A., Murakami K., Doki Y. Clinical trial of ghrelin synthesis administration for upper GI surgery. Methods Enzymol 514 409-431 2012
5
Eguchi H., Tanemura M., Marubashi S., Kobayashi S., Wada H., Okita K., Iwahashi H., Imagawa A., Shimomura I., Osuga K., Umeshita K., Wakasa K., Mori M., Doki Y., Nagano H. Arterial stimulation and venous sampling for glucagonomas of the pancreas. Hepatogastroenterology 59 276-279 2012
6
Miyata H., Yano M., Yasuda T., Hamano R., Yamasaki M., Hou E., Motoori M., Shiraishi O., Tanaka K., Mori M., Doki Y. Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr 31 330-336 2012
7
Miyata H., Yamasaki M., Kurokawa Y., Takiguchi S., Nakajima K., Fujiwara Y., Mori M., Doki Y. Clinical relevance of induction triplet chemotherapy for esophageal cancer invading adjacent organs. J Surg Oncol 106 441-447 2012
8
Mizushima T., Ikeda M., Sekimoto M., Yamamoto H., Doki Y., Mori M. Laparoscopic bladder-preserving surgery for enterovesical fistula complicated with benign gastrointestinal disease. Case Rep Gastroenterol 6 279-284 2012
9
Nakajima K., Moon JH., Tsutsui S., Miyazaki Y., Yamasaki M., Yamada T., Kato M., Yasuda K., Sumiyama K., Yahagi N., Saida Y., Kondo H., Nishida T., Mori M., Doki Y. Esophageal submucosal dissection under steady pressure automatically controlled endoscopy: a preclinical trial in swine. Endoscopy 44 1139-1147 2012
10
Takemasa I., Kittaka N., Hitora T., Watanabe M., Matsuo E., Mizushima T., Ikeda M., Yamamoto H., Sekimoto M., Nishimura O., Doki Y., Mori M. Potential biological insights revealed by an integrated assessment of proteomic and transcriptomic data in human colorectal cancer. Int J Oncol 40 551-559 2012
11
Kobayashi S., Nagano H., Marubashi S., Wada H., Eguchi H., Takeda Y., Tanemura M., Doki Y., Mori M. Fibrin Sealant with PGA felt for Prevention of Bile Leakage after Liver Resection. Hepatogastroenterology 59 2564-2568 2012
12
Marubashi S., Umeshita K., Asahara T., Fujiwara K., Haga H., Hashimoto T., Hatakeyama K., Ichida T., Kanematsu T., Kitajima M., Kiyosawa K., Makuuchi M., Miyagawa S., Satomi S., Soejima Y., Takada Y., Tanaka N., Teraoka S., Monden M. Steroid-free living donor liver transplantation for HCV--a multicenter prospective cohort study in Japan. Clin Transplant 26 857-867 2012
13
Kobayashi S., Nagano H., Marubashi S., Wada H., Eguchi H., Takeda Y., Tanemura M., Doki Y., Mori M. Fibrin Sealant with PGA felt for Prevention of Bile Leakage after Liver Resection. Hepatogastroenterology 59 2564-2568 2012
14
Kawamoto K., Pahuja A., Nettles A., Honkanen-Scott M., Bansal-Pakala P. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes. Autoimmunity 45 310-319 2012
15
Nishimura J., Handa R., Yamamoto H., Tanaka F., Shibata K., Mimori K., Takemasa I., Mizushima T., Ikeda M., Sekimoto M., Ishii H., Doki Y., Mori M. microRNA-181a is associated with poor prognosis of colorectal cancer. Oncol Rep 28 2221-2226 2012
16
Miyazaki S., Yamamoto H., Miyoshi N., Takahashi H., Suzuki Y., Haraguchi N., Ishii H., Doki Y., Mori M. Emerging methods for preparing iPS cells. Jpn J Clin Oncol 42 773-779 2012
17
Uemura M., Ikeda M., Sekimoto M., Noura S., Ohue M., Mizushima T., Yamamoto H., Takemasa I., Yano M., Ishikawa O., Doki Y., Mori M. The features of late local recurrences following curative surgery for rectal cancer. Hepatogastroenterology 59 1800-1803 2012
18
Hara J., Nakajima K., Takahashi T., Yamasaki M., Miyata H., Kurokawa Y., Takiguchi S., Mori M., Doki Y. Laparoscopic intragastric surgery revisited: its role for submucosal tumors adjacent to the esophagogastric junction. Surg Laparosc Endosc Percutan Tech 22 251-254 2012
19
Hiura Y., Takiguchi S., Yamamoto K., Takahashi T., Kurokawa Y., Yamasaki M., Nakajima K., Miyata H., Fujiwara Y., Mori M., Kangawa K., Doki Y. Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study. Cancer 118 4785-4794 2012
20
Hiura Y., Takiguchi S., Yamamoto K., Kurokawa Y., Yamasaki M., Nakajima K., Miyata H., Fujiwara Y., Mori M., Doki Y. Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients. Int J Clin Oncol 17 316-323 2012
21
Kagawa Y., Hata S., Shimizu J., Sekimoto M., Mori M. Transumbilical laparoscopic-assisted appendectomy for children and adults. Int J Colorectal Dis 27 411-413 2012
22
Miyagaki H., Nakajima K, Hara J, Yamasaki M, Kurokawa Y, Miyata H, Takiguchi S, Fujiwara Y, Mori M, Doki Y. Performance comparison of peripherally inserted central venous catheters in gastrointestinal surgery: a randomized controlled trial. Clin Nutr 31 48-52 2012
23
Miyagaki H., Yamasaki M., Takahashi T., Kurokawa Y., Miyata H., Nakajima K., Takiguchi S., Fujiwara Y., Mori M., Doki Y. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection. Ann Surg Oncol 19 1560-1567 2012
24
Miyagaki H., Kurokawa Y., Hirao M., Tamura S., Nishida T., Kimura Y., Fujiwara., Mori M., Doki Y. Recent trend of internal hernia occurrence after gastrectomy for gastric cancer. World J Surg 36 851-857 2012
25
Miyagaki H., Yamasaki M., Miyata H., Takahashi T., Kurokawa Y., Nakajima K., Takiguchi S., Fujiwara Y., Ishii H., Tanaka F., Mori M., Doki Y. Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma. Br J Cancer 106 947-954 2012
26
Miyazaki Y., Nakajima K., Yamasaki M., Miyata H., Kurokawa Y., Takiguchi S., Fujiwara Y., Mori M., Doki Y. Single-port laparoscopic surgery of the distal esophagus: initial clinical experience. Surg Laparosc Endosc Percutan Tech 22 118-121 2012
27
Sugimura K., Miyata H., Tanaka K., Hamano R.,Takahashi T.,Kurokawa Y.,Yamasaki M., Nakajima K., Takiguchi S., Mori M., Doki Y. Let-7 expression is significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res 18 5144-5153 2012
28
Takahashi H., Haraguchi N., Nishikawa S., Miyazaki S., Suzuki Y., Mizushima T., Nishimura J., Takemasa I., Yamamoto H., Mimori K., Ishii H., Doki Y., Mori M. Biological and clinical availability of adipose-derived stem cells for pelvic dead space repair. Stem Cells Transl Med 1 803-810 2012
29
Yamashita S., Yamamoto H., Mimori K., Nishida N., Takahashi H., Haraguchi N., Tanaka F., Shibata K., Sekimoto M., Ishii H., Doki Y., Mori M. MicroRNA-372 is associated with poor prognosis in colorectal cancer. Oncology 82 205-212 2012
30
Fujiwara S., Wada H., Miyata H., Kawada J., Kawabata R., Nishikawa H., Gnjatic S., Sedrak C., Sato E., Nakamura Y., Sakakibara M., Kanto T., Shimosegawa E., Hatazawa J., Takahashi T., Kurokawa Y., Yamasaki M., Nakajima K., Takiguchi S., Nakayama E., Mori M., Doki Y. Clinical trial of the intratumoral administration of labeled DC combined with systemic chemotherapy for esophageal cancer. J Immunother 35 513-521 2012
31
Okada K., Fujiwara Y., Nakamura Y., Takiguchi S., Nakajima K., Miyata H., Yamasaki M., Kurokawa Y., Takahashi T., Mori M., Doki Y. Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma. J Surg Oncol 105 780-785 2012
32
Tanaka K., Yano M., Motoori M., Doki Y., Kishi K., Miyashiro I., Shingai T., Gotoh K., Noura S., Takahashi H., Ohue M., Yamada T., Ohigashi H., Ishikawa O. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer. Dis Esophagus 25 146-152 2012
33
Tanaka K., Yano M., Motoori M., Kishi K., Miyashiro I., Ohue M., Ohigashi H., Asahara T., Nomoto K., Ishikawa O. Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial. Surgery 152 832-842 2012
34
Tomimaru Y., Eguchi H., Nagano H., Wada H., Kobayashi S., Marubashi S., Tanemura M., Tomokuni A., Takemasa I., Umeshita K., Kanto T., Doki Y., Mori M. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 56 167-175 2012
35
Tomimaru Y., Eguchi H., Wada H., Kobayashi S., Marubashi S., Tanemura M., Umeshita K., Kim T., Wakasa K., Doki Y., Mori M., Nagano H. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma. Int J Cancer 130 319-327 2012
36
Hirota M., Nakajima K., Hara J., Takahashi T., Yamasaki M., Tsutsui T., Kobayashi E., Kurokawa Y., Miyata H., Takiguchi S., Mori M., Doki Y. A case of simultaneous transvaginal NOTES gastrectomy and vaginal hysterectomy in a patient with gastric submucosal tumor and uterine prolapse. Asian J Endosc Surg 5 168-171 2012
37
Ogino T., Sekimoto M., Nishimura J., Takemasa I., Mizushima T., Ikeda M., Yamamoto H., Doki Y., Mori M. Intraluminal migration of a spacer with small bowel obstruction: a case report of rare complication. World J Surg Oncol 10 1-4 2012
38
Yamada D., Kobayashi S., Yamamoto H., Tomimaru Y., Noda T., Uemura M., Wada H., Marubashi S., Eguchi H., Tanemura M., Doki Y., Mori M., Nagano H. Role of the Hypoxia-Related Gene, JMJD1A, in Hepatocellular Carcinoma: Clinical Impact on Recurrence after Hepatic Resection. Ann Surg Oncol 19 355-364 2012
39
Nishikawa S., Ishii H., Haraguchi N., Kano Y., Fukusumi T., Ohta K., Ozaki M., Sakai D., Satoh T., Nagano H., Doki Y., Mori M. Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cells. Exp Ther Med 3 959-962 2012
40
Nishikawa S., Ishii H., Haraguchi N., Kano Y., Fukusumi T., Ohta K., Ozaki M., Dewi DL., Sakai D., Satoh T., Nagano H., Doki Y., Mori M. microRNA-based cancer cell reprogramming technology (Review) Exp Ther Med 4 8-14 2012
41
Nishikawa S., Dewi D., Ishii H., Konno M., Haraguchi N, Kano Y., Fukusumi T., Ohta K., Noguchi Y., Ozaki M., Sakai D., Satoh T., Doki Y., Mori M. Transcriptomic study of dormant gastrointestinal cancer stem cells. Int J Oncol 41 979-984 2012
42
Dewi D., Ishii H., Haraguchi N., Nishikawa S., Kano Y., Fukusumi T., Ohta K., Miyazaki S., Ozaki M., Sakai D., Satoh T., Nagano H., Doki Y., Mori M. Reprogramming of gastrointestinal cancer cells. Cancer Sci 103 393-399 2012
43
Kim C., Aono S., Marubashi S., Wada H., Kobayashi S., Eguchi H., Takeda Y., Tanemura M., Okumura N., Takao T., Doki Y., Mori M., Nagano H. Significance of alanine aminopeptidase N (APN) in bile in the diagnosis of acute cellular rejection after liver transplantation. J Surg Res 175 138-148 2012
44
Kubota M., Murakami T., Nagano H., Eguchi H., Marubashi S., Kobayashi S., Wada H., Tanemura M., Dono K., Nakamori S., Sakon M., Monden M., Mori M., Doki Y. Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumor. Dig Dis Sci 57 801-805 2012
45
Masuzawa T., Fujiwara Y., Okada K., Nakamura A., Takiguchi S., Nakajima K., Miyata H., Yamasaki M., Kurokawa Y., Osawa R., Takeda K., Yoshida K., Tsunoda T., Nakamura Y., Mori M., Doki Y. Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer. Int J Oncol 41 1297-1304 2012
46
Noda T., Yamamoto H., Takemasa I., Yamada D., Uemura M., Wada H., Kobayashi S., Marubashi S., Eguchi H., Tanemura M., Umeshita K., Doki Y., Mori M., Nagano H. PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection. Liver Int 32 110-118 2012
47
Yoshioka Y., Shimizu S., Ito T., Taniguchi M., Nomura M., Nishida T., Sawa Y. p53 inhibits vascular endothelial growth factor expression in solid tumor. J Surg Res 174 291-297 2012